RT Book, Section
A1 Cyrus, Nika
A1 Jacobe, Heidi T.
A2 Kang, Sewon
A2 Amagai, Masayuki
A2 Bruckner, Anna L.
A2 Enk, Alexander H.
A2 Margolis, David J.
A2 McMichael, Amy J.
A2 Orringer, Jeffrey S.
SR Print(0)
ID 1161332682
T1 Morphea and Lichen Sclerosus
T2 Fitzpatrick's Dermatology, 9e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9780071837798
LK dermatology.mhmedical.com/content.aspx?aid=1161332682
RD 2024/04/24
AB AT-A-GLANCEOccurs  in  children  and  adults.Linear  subtype  predominates  in  children.Circumscribed  and  generalized  predominate  in  adults.A  self-limited  or  chronically  relapsing  autoimmune  disorder  targeting  the  skin  with  the  following  major  features:Inflammatory,  sclerotic,  atrophic  phases.Thickened  sclerotic  skin.Systemic  disease,  including  arthritis  and  neurologic  disorders,  in  a  minority.Differentiated  from  scleroderma  by  lack  of  acrosclerosis/sclerodactyly.Complications  may  cause  significant  irreversible  cosmetic  and  functional  impairment  including  the  following:Atrophy  of  dermis,  fat,  and  subcutaneous  structures.Contracture.Limb-length  discrepancy.Bony  abnormalities.Effective  treatment  reduces  signs  of  disease  activity  and  does  not  produce  complete  resolution  of  lesions.  Treatment  based  on  the  following:Disease  subtype.Depth  of  involvement.Stage  (inflammatory,  sclerotic,  atrophic).Potential  for  complications.